Taiwanese Startups Secure Over 100 Meetings at BIO 2026
Six Taiwanese biomedical startups participated in the BIO 2026 convention in San Diego in June. The event facilitated over 100 business meetings with global pharmaceutical companies, investors, and research organizations.
Six Taiwanese biomedical startups participated in the BIO International Convention 2026, held from June 22 to 25 in San Diego. During the event, the startups held more than 100 one-on-one business meetings with potential international partners, investors, and pharmaceutical companies.
The convention served as a platform for the Taiwanese companies to showcase their technologies and explore global collaboration opportunities. BIO International Convention is one of the largest gatherings in the biotechnology sector, attracting industry leaders worldwide.
This participation was part of Taiwan's governmental efforts to support the growth and internationalization of its biotechnology sector. The initiative aims to facilitate market access for local startups and attract foreign investment into the industry.